Skip to content

Released May 10, 2012

10-Q filed May 10, 2012, 40 days after period end · 0001104659-12-035583

Q1 2012 · 10-Q
Revenue$12.25M+19.6% vs Q1 2011−61.9% vs Q4 2011
Net income—
EPS Diluted-$0.34N/M vs Q1 2011N/M vs Q4 2011
Operating Income-$35,636,000N/M
Operating Cash Flow-$43,062,000N/M
Free Cash Flowderived-$47,704,000N/M
Margins · derived
Operating margin-291.0%−109.8 pt vs Q1 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2012Q1 2011Q1 2010
Revenue$12.25M$10.24M$8.84M
Net Income—-$18.40M-$16.25M
EPS Diluted-$0.34-$0.19-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR